-
EP2066693
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2066693
| EP2066693 - MODULATING REGULATORY T CELL ACTIVITY VIA INTERLEUKIN 35 [Right-click to bookmark this link] | Status | The application has been refused Status updated on 08.09.2017 Database last updated on 24.08.2024 | Most recent event Tooltip | 08.09.2017 | Refusal of application | published on 11.10.2017 [2017/41] | Applicant(s) | For all designated states ST. JUDE CHILDREN'S RESEARCH HOSPITAL 332 N. Lauderdale Street Memphis, TN 38105-2794 / US | [2009/24] | Inventor(s) | 01 /
VIGNALI, Dario 2900 Waterleaf Drive Germantown, TN 38138 / US | 02 /
WORKMAN, Creg 1669 Autumn Avenue Memphis, TN 38112 / US | 03 /
COLLISON, Lauren 1363 Island Town Drive Memphis, TN 38103 / US | 04 /
VIGNALI, Kate 2900 Waterleaf Drive Germantown, TN 38138 / US | [2009/24] | Representative(s) | Truscott, Glyn John Elkington and Fife LLP Thavies Inn House 3-4 Holborn Circus London EC1N 2HA / GB | [N/P] |
| Former [2009/24] | Bentham, Andrew J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 07853605.9 | 24.09.2007 | [2009/24] | WO2007US79310 | Priority number, date | US20060846434P | 22.09.2006 Original published format: US 846434 P | [2009/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008036973 | Date: | 27.03.2008 | Language: | EN | [2008/13] | Type: | A2 Application without search report | No.: | EP2066693 | Date: | 10.06.2009 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.03.2008 takes the place of the publication of the European patent application. | [2009/24] | Search report(s) | International search report - published on: | EP | 19.06.2008 | Classification | IPC: | C07K14/52, C07K14/715, C07K14/54 | [2009/24] | CPC: |
C07K16/244 (EP,US);
A61K39/39533 (US);
A61K39/3955 (US);
A61K39/4611 (EP,US);
A61K39/4621 (EP,US);
A61K39/46433 (EP,US);
A61P35/00 (EP);
C12N5/0636 (EP,US);
A61K2039/505 (US);
C07K2317/21 (US);
C07K2317/24 (US);
C07K2317/35 (US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/24] | Extension states | AL | 27.03.2009 | BA | 27.03.2009 | HR | 27.03.2009 | MK | 27.03.2009 | RS | 27.03.2009 | Title | German: | MODULATION DER REGULATORISCHEN AKTIVITÄT VON T-ZELLEN MITTELS INTERLEUKIN-35 | [2009/24] | English: | MODULATING REGULATORY T CELL ACTIVITY VIA INTERLEUKIN 35 | [2009/24] | French: | MODULATION DE L'ACTIVITÉ RÉGULATRICE DES LYMPHOCYTES T VIA L'INTERLEUKINE 35 | [2009/24] | Entry into regional phase | 27.03.2009 | National basic fee paid | 27.03.2009 | Designation fee(s) paid | 27.03.2009 | Examination fee paid | Examination procedure | 27.03.2009 | Amendment by applicant (claims and/or description) | 27.03.2009 | Examination requested [2009/24] | 15.10.2010 | Despatch of a communication from the examining division (Time limit: M06) | 05.04.2011 | Reply to a communication from the examining division | 28.01.2014 | Date of oral proceedings | 13.06.2014 | Despatch of communication that the application is refused, reason: substantive examination [2017/41] | 13.06.2014 | Minutes of oral proceedings despatched | 11.08.2017 | Application refused, date of legal effect [2017/41] | Appeal following examination | 13.08.2014 | Appeal received No. T2163/14 | 13.10.2014 | Statement of grounds filed | 11.08.2017 | Result of appeal procedure: appeal of the applicant withdrawn | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 15.10.2010 | Fees paid | Renewal fee | 27.03.2009 | Renewal fee patent year 03 | 27.09.2010 | Renewal fee patent year 04 | 26.09.2011 | Renewal fee patent year 05 | 25.09.2012 | Renewal fee patent year 06 | 27.09.2013 | Renewal fee patent year 07 | 29.09.2014 | Renewal fee patent year 08 | 28.09.2015 | Renewal fee patent year 09 | 27.09.2016 | Renewal fee patent year 10 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO9412519 (BRIGHAM & WOMENS HOSPITAL [US]); | [DX]WO9713859 (BRIGHAM & WOMENS HOSPITAL [US]); | [X]US5744301 (BIRKENBACH MARK [US], et al); | [X]EP0894854 (SMITHKLINE BEECHAM CORP [US]); | [X]WO0140257 (MAXYGEN INC [US], et al); | [X]WO2005079848 (SCHERING CORP [US], et al); | [X]WO2005090400 (UNIV GLASGOW [GB], et al); | [PX]WO2007045389 (UNIV MAINZ JOHANNES GUTENBERG [DE], et al); |